
|Articles|October 1, 2017
- Pharmaceutical Executive-10-01-2017
- Volume 37
- Issue 10
Pharmaceutical Executive, October 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharm Exec's Emerging Pharma Leaders 2017over 8 years ago
How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’over 8 years ago
Glimmers of Hope for Innovation Support in Europeover 8 years ago
The Future of Real-World Studiesover 8 years ago
Inspiring People, Inspiring Teamsover 8 years ago
Country Report: ColombiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Evolving Relationship Between FDA and Biotech
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
The Implications of GLP-1s Replacing Oncology as the Key Value Driver
4
Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi
5




